• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在晚期卵巢癌治疗中,最大程度的手术努力会增加术后并发症的风险。

Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer.

作者信息

Kuusela Kati, Norppa Niina, Auranen Annika, Saarelainen Sami

机构信息

Tampere University, FI-33014, Tampere, Finland.

Tampere University Hospital, Department of Obsteterics and Gynecology, PO BOX 2000, FI-33521, Tampere, Finland.

出版信息

Eur J Surg Oncol. 2022 Dec;48(12):2525-2530. doi: 10.1016/j.ejso.2022.06.007. Epub 2022 Jun 9.

DOI:10.1016/j.ejso.2022.06.007
PMID:35717320
Abstract

INTRODUCTION

Surgery is the cornerstone of the treatment for advanced ovarian cancer. Reaching complete cytoreduction resulting in no gross residual disease often requires complex surgery. The aim of this study was to assess the impact of increased surgical radicality on the risk of complications in the treatment of advanced ovarian cancer.

MATERIALS AND METHODS

All consecutive patients with advanced ovarian cancer (FIGO Stage IIIB-IVB) who had undergone primary or interval debulking surgery during a six-year study period were identified. In the midst of the study period, a surgical practice change towards maximal surgical effort occurred. Two groups were formed for the analysis: cohort A, that consisted of patients operated before the surgical paradigm shift and cohort B, that consisted of patients operated under the period of increased surgical radicality.

RESULTS

252 patients were included in the analysis. Complete resection (R0) was achieved in 21.3% of surgeries in cohort A and in 51.2% in cohort B. The total postoperative complication rate was 76.2%. Most of the complications (86.5%) were minor (Clavien-Dindo I-IIIA). The patients in cohort B were at increased risk for complications, OR 2.94 (95%CI 1.58-5.47; p = 0.001). As for the approach to cytoreduction (primary vs. interval debulking), there was no statistically significant association with the occurrence of postoperative complications (p = 0.659).

CONCLUSION

In the present study more extensive surgeries led to better surgical results but increased postoperative morbidity. Postoperative complication rates were similar in both primary and interval debulking surgeries.

摘要

引言

手术是晚期卵巢癌治疗的基石。实现完全细胞减灭术从而无肉眼可见残留病灶通常需要复杂的手术。本研究的目的是评估在晚期卵巢癌治疗中增加手术彻底性对并发症风险的影响。

材料与方法

确定了在为期六年的研究期间接受初次或间隔性肿瘤细胞减灭术的所有连续晚期卵巢癌患者(国际妇产科联盟(FIGO)分期IIIB-IVB)。在研究期间,手术实践向最大程度的手术努力发生了转变。形成两组进行分析:队列A,由手术模式转变前接受手术的患者组成;队列B,由在手术彻底性增加时期接受手术的患者组成。

结果

252例患者纳入分析。队列A中21.3%的手术实现了完全切除(R0),队列B中这一比例为51.2%。术后总并发症发生率为76.2%。大多数并发症(86.5%)为轻度(Clavien-Dindo I-IIIA级)。队列B中的患者发生并发症的风险增加,比值比为2.94(95%置信区间1.58-5.47;p = 0.001)。至于细胞减灭术的方式(初次与间隔性肿瘤细胞减灭术),与术后并发症的发生无统计学显著关联(p = 0.659)。

结论

在本研究中,更广泛的手术带来了更好的手术效果,但术后发病率增加。初次和间隔性肿瘤细胞减灭术的术后并发症发生率相似。

相似文献

1
Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer.在晚期卵巢癌治疗中,最大程度的手术努力会增加术后并发症的风险。
Eur J Surg Oncol. 2022 Dec;48(12):2525-2530. doi: 10.1016/j.ejso.2022.06.007. Epub 2022 Jun 9.
2
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.新辅助化疗后延迟细胞减灭术治疗晚期上皮性卵巢癌的生存结局。
Int J Gynecol Cancer. 2020 Dec;30(12):1935-1942. doi: 10.1136/ijgc-2020-001658. Epub 2020 Oct 29.
3
Postoperative complications in women with ovarian cancer stratified by cytoreductive surgery outcome.卵巢癌患者按细胞减灭术结果分层的术后并发症。
J Surg Oncol. 2023 Oct;128(5):891-901. doi: 10.1002/jso.27380. Epub 2023 Jun 29.
4
A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.一种新的晚期卵巢癌间歇肿瘤减灭术后残留病灶分类方法,可更好地区分肿瘤学结局。
Am J Obstet Gynecol. 2019 Oct;221(4):326.e1-326.e7. doi: 10.1016/j.ajog.2019.05.006. Epub 2019 May 10.
5
Ultra-radical surgery versus standard-radical surgery for the primary cytoreduction of advanced epithelial ovarian cancer; long-term tertiary center experiences.超根治性手术与标准根治性手术治疗晚期上皮性卵巢癌的初次细胞减灭术:长期三级中心经验。
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:125-133. doi: 10.1016/j.ejogrb.2024.09.005. Epub 2024 Sep 7.
6
Ultra-radical surgery for advanced ovarian cancer: a retrospective cohort study in a tertiary referral cancer center in the UK.英国一家三级转诊癌症中心的一项回顾性队列研究:晚期卵巢癌的超根治性手术。
Minerva Obstet Gynecol. 2024 Aug;76(4):319-326. doi: 10.23736/S2724-606X.22.05179-X. Epub 2023 Apr 14.
7
The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer.主要术后并发症对卵巢癌细胞减灭术后复发和长期生存的影响。
Gynecol Oncol. 2022 Jul;166(1):8-17. doi: 10.1016/j.ygyno.2022.05.002. Epub 2022 May 12.
8
Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay.卵巢癌初次手术的术后并发症及其对化疗延迟的影响。
Curr Oncol. 2024 Sep 19;31(9):5630-5642. doi: 10.3390/curroncol31090417.
9
Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis.在晚期上皮性卵巢癌中,初次肿瘤细胞减灭术时的微小残留病灶与间隔性肿瘤细胞减灭术时的完全肿瘤切除相比:一项生存分析。
Gynecol Oncol. 2020 Apr;157(1):209-213. doi: 10.1016/j.ygyno.2020.01.010. Epub 2020 Jan 15.
10
Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit.手术量对晚期卵巢癌细胞减灭术短期结局的影响:荷兰妇科肿瘤学审计的一项基于人群的研究。
Gynecol Oncol. 2024 Jul;186:144-153. doi: 10.1016/j.ygyno.2024.04.002. Epub 2024 Apr 30.

引用本文的文献

1
Selective Advantage of NACT in Advanced Ovarian Cancer: A Retrospective Single-Centre Analysis.新辅助化疗在晚期卵巢癌中的选择性优势:一项回顾性单中心分析
Medicina (Kaunas). 2025 Aug 20;61(8):1493. doi: 10.3390/medicina61081493.
2
Postoperative Complications After Cytoreductive Surgery for Advanced Ovarian Carcinoma: A Single-Center Analysis Exploring the Value of the Comprehensive Complication Index and the Predictors of High Complications Burden.晚期卵巢癌肿瘤细胞减灭术后的并发症:一项探索综合并发症指数价值及高并发症负担预测因素的单中心分析
Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17619-9.
3
Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery.
卵巢癌手术中的术中液体平衡与围手术期并发症。
Ann Surg Oncol. 2024 Dec;31(13):8944-8951. doi: 10.1245/s10434-024-16246-0. Epub 2024 Oct 8.
4
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).接受细胞减灭术和腹腔内热灌注化疗(CRS/HIPEC)治疗的罕见卵巢癌腹膜转移。
Pleura Peritoneum. 2023 Dec 27;9(1):15-22. doi: 10.1515/pp-2023-0019. eCollection 2024 Mar.
5
Survival impact and safety of intrathoracic and abdominopelvic cytoreductive surgery in advanced ovarian cancer: a systematic review and meta-analysis.晚期卵巢癌胸腹腔减瘤手术的生存影响及安全性:一项系统评价和荟萃分析
Front Oncol. 2024 Jan 18;14:1335883. doi: 10.3389/fonc.2024.1335883. eCollection 2024.
6
Maximal Effort Cytoreduction in Epithelial Ovarian Cancer: Perioperative Complications and Survival Outcomes from a Retrospective Cohort.上皮性卵巢癌的最大程度细胞减灭术:一项回顾性队列研究的围手术期并发症及生存结局
J Clin Med. 2023 Jan 12;12(2):622. doi: 10.3390/jcm12020622.